-
Early Trial for Microdystrophin Showcases Gene Therapy’s Promise
Microdystrophin gene therapy reduced muscle damage in Duchenne muscular dystrophy (DMD), according to results of a Phase 1/2 clinical trial. Learn more about the trial and its results here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.